Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Jun;80(3):467–473. doi: 10.1111/j.1365-2249.1990.tb03311.x

Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice.

H Carlsten 1, A Tarkowski 1, R Holmdahl 1, L A Nilsson 1
PMCID: PMC1535196  PMID: 2372993

Abstract

The influence of oestrogen on the lupus disease in MRL/l mice has been investigated. Adult, castrated male and female MRL/l mice were administered with s.c. injections of 3.2 micrograms of 17 beta-oestradiol twice a week. The results clearly demonstrate that a relatively small dose of oestrogen is a potent accelerator of the lupus disease in this mouse strain. Thus, administration of oestrogen accelerates glomerulonephritis, lymphoproliferation and mortality. Our results also indicate that oestrogen exerts a dual effect on the immune system of MRL/l mice by depression of antigen-specific and mitogen-induced T cell responses as well as enhancement of polyclonal B cell activation and autoantibody formation. In addition, even short-term administration of oestrogen in the preclinical phase of the disease resulted in long-lasting effects as evaluated by reduced longevity and aggravation of renal disease.

Full text

PDF
472

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ansar Ahmed S., Dauphinée M. J., Montoya A. I., Talal N. Estrogen induces normal murine CD5+ B cells to produce autoantibodies. J Immunol. 1989 Apr 15;142(8):2647–2653. [PubMed] [Google Scholar]
  3. Carlsten H., Holmdahl R., Tarkowski A., Nilsson L. A. Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology. 1989 Jun;67(2):205–209. [PMC free article] [PubMed] [Google Scholar]
  4. Carlsten H., Holmdahl R., Tarkowski A., Nilsson L. A. Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology. 1989 Oct;68(2):209–214. [PMC free article] [PubMed] [Google Scholar]
  5. Carlsten H., Nilsson L. A., Tarkowski A. Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol. 1986;81(4):322–325. doi: 10.1159/000234156. [DOI] [PubMed] [Google Scholar]
  6. Coulie P. G., Van Snick J. Rheumatoid factor (RF) production during anamnestic immune responses in the mouse. III. Activation of RF precursor cells is induced by their interaction with immune complexes and carrier-specific helper T cells. J Exp Med. 1985 Jan 1;161(1):88–97. doi: 10.1084/jem.161.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Czerkinsky C. C., Nilsson L. A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983 Dec 16;65(1-2):109–121. doi: 10.1016/0022-1759(83)90308-3. [DOI] [PubMed] [Google Scholar]
  8. Elwing H., Nygren H. Diffusion in gel-enzyme linked immunosorbent assay (DIG-ELISA): a simple method for quantitation of class-specific antibodies. J Immunol Methods. 1979;31(1-2):101–107. doi: 10.1016/0022-1759(79)90290-4. [DOI] [PubMed] [Google Scholar]
  9. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  10. Grossman C. J. Regulation of the immune system by sex steroids. Endocr Rev. 1984 Summer;5(3):435–455. doi: 10.1210/edrv-5-3-435. [DOI] [PubMed] [Google Scholar]
  11. Holmdahl R., Carlsten H., Jansson L., Larsson P. Oestrogen is a potent immunomodulator of murine experimental rheumatoid disease. Br J Rheumatol. 1989;28 (Suppl 1):54–71. doi: 10.1093/rheumatology/xxviii.suppl_1.54. [DOI] [PubMed] [Google Scholar]
  12. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  13. Jansson L., Holmdahl R. Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. J Reprod Immunol. 1989 May;15(2):141–150. doi: 10.1016/0165-0378(89)90033-8. [DOI] [PubMed] [Google Scholar]
  14. Lahita R. G. Sex steroids and the rheumatic diseases. Arthritis Rheum. 1985 Feb;28(2):121–126. doi: 10.1002/art.1780280202. [DOI] [PubMed] [Google Scholar]
  15. Lue C., Tarkowski A., Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol. 1988 Jun 1;140(11):3793–3800. [PubMed] [Google Scholar]
  16. Lycke N., Bromander A. K., Ekman L., Karlsson U., Holmgren J. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J Immunol. 1989 Jan 1;142(1):20–27. [PubMed] [Google Scholar]
  17. MUND A., SIMSON J., ROTHFIELD N. Effect of pregnancy on course of systemic lupus erythematosus. JAMA. 1963 Mar 16;183:917–920. doi: 10.1001/jama.1963.03700110049009. [DOI] [PubMed] [Google Scholar]
  18. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  19. Prud'homme G. J., Fieser T. M., Dixon F. J., Theofilopoulos A. N. B-cell-tropic interleukins in murine systemic lupus erythematosus (SLE) 1. Immunol Rev. 1984 Apr;78:159–183. doi: 10.1111/j.1600-065x.1984.tb00481.x. [DOI] [PubMed] [Google Scholar]
  20. Rosenberg Y. J., Malek T. R., Schaeffer D. E., Santoro T. J., Mark G. E., Steinberg A. D., Mountz J. D. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr mice. J Immunol. 1985 May;134(5):3120–3123. [PubMed] [Google Scholar]
  21. Roubinian J. R., Talal N., Greenspan J. S., Goodman J. R., Siiteri P. K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med. 1978 Jun 1;147(6):1568–1583. doi: 10.1084/jem.147.6.1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Russell M. W., Brown T. A., Radl J., Haaijman J. J., Mestecky J. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods. 1986 Feb 27;87(1):87–93. doi: 10.1016/0022-1759(86)90347-9. [DOI] [PubMed] [Google Scholar]
  23. Shear H. L., Wofsy D., Talal N. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. Clin Immunol Immunopathol. 1983 Mar;26(3):361–369. doi: 10.1016/0090-1229(83)90120-4. [DOI] [PubMed] [Google Scholar]
  24. Siiteri P. K., Jones L. A., Roubinian J., Talal N. Sex steroids and the immune system--I. Sex difference in autoimmune disease in NZB/NZW hybrid mice. J Steroid Biochem. 1980 Jan;12:425–432. doi: 10.1016/0022-4731(80)90303-9. [DOI] [PubMed] [Google Scholar]
  25. Steinberg A. D., Melez K. A., Raveche E. S., Reeves J. P., Boegel W. A., Smathers P. A., Taurog J. D., Weinlein L., Duvic M. Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum. 1979 Nov;22(11):1170–1176. doi: 10.1002/art.1780221103. [DOI] [PubMed] [Google Scholar]
  26. Steinberg A. D., Roths J. B., Murphy E. D., Steinberg R. T., Raveche E. S. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol. 1980 Aug;125(2):871–873. [PubMed] [Google Scholar]
  27. Tarkowski A., Czerkinsky C., Nilsson L. A. Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin Exp Immunol. 1984 Oct;58(1):7–12. [PMC free article] [PubMed] [Google Scholar]
  28. Tarkowski A., Gunnarsson K., Nilsson L. A., Lindholm L., Stålhandske T. Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator. Arthritis Rheum. 1986 Nov;29(11):1405–1409. doi: 10.1002/art.1780291115. [DOI] [PubMed] [Google Scholar]
  29. Tarkowski A., Gunnarsson K., Stålhandske T. Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice. Immunology. 1986 Dec;59(4):589–594. [PMC free article] [PubMed] [Google Scholar]
  30. Tarkowski A., Jonsson R., Sanchez R., Klareskog L., Koopman W. J. Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells. Clin Exp Immunol. 1988 Apr;72(1):91–97. [PMC free article] [PubMed] [Google Scholar]
  31. Theofilopoulos A. N., Dixon F. J. Etiopathogenesis of murine SLE. Immunol Rev. 1981;55:179–216. doi: 10.1111/j.1600-065x.1981.tb00343.x. [DOI] [PubMed] [Google Scholar]
  32. Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390. doi: 10.1016/s0065-2776(08)60342-9. [DOI] [PubMed] [Google Scholar]
  33. Warren R. W., Caster S. A., Roths J. B., Murphy E. D., Pisetsky D. S. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin Immunol Immunopathol. 1984 Apr;31(1):65–77. doi: 10.1016/0090-1229(84)90190-9. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES